Development of a UFLC-MS/MS method for the simultaneous determination of seven tea catechins in rat plasma and its application to a pharmacokinetic study after administration of green tea extract

Journal of Pharmaceutical and Biomedical Analysis

Volumn 125, Issue , 2016, Pages 229-235

  Huo, Yanshuang ^a   Zhang, Qian ^a   Li, Qing ^a   Geng, Bingjie ^a   Bi, Kaishun ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Catechins; Green tea extract; MS MS; Pharmacokinetics; UFLC

Indexed keywords

2 PROPANOL; ACETIC ACID ETHYL ESTER; CATECHIN; EPICATECHIN; EPICATECHIN 3 GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GALLOCATECHIN; GALLOCATECHIN 3 GALLATE; GREEN TEA EXTRACT; UNCLASSIFIED DRUG; TEA;

ANIMAL EXPERIMENT; ARTICLE; CALIBRATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG STRUCTURE; ELUTION; LIQUID LIQUID EXTRACTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ANIMAL; BLOOD; CHEMISTRY; PROCEDURES; TANDEM MASS SPECTROMETRY; TEA;

ANIMALS; CATECHIN; RATS; TANDEM MASS SPECTROMETRY; TEA;

EID: 84962265450     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2016.03.048     Document Type: Article

References (17)

1. Bettuzzi S., Brausi M., Rizzi F., Castagnetti G., Peracchia G., Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res. 2006, 66:1234-1240.
2. Miura Y., Chiba T., Tomita I., Koizumi H., Miura S., Umegaki K., Hara Y., Ikeda M., Tomita T. Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J. Nutr. 2001, 131:27-32.
3. Yokozawa T., Nakagawa T., Kitani K. Antioxidative activity of green tea polyphenols in cholesterol fed rats. Agric. Food Chem. 2002, 50:3549-3552.
4. Murase T., Nagasawa A., Suzuki J., Hase T., Tokimitsu I. Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver. Int. J. Obes. 2002, 26:1459-1464.
5. Sabu M.C., Smitha K., Kuttan R. Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes. J. Ethnopharmacol. 2002, 83:109-116.
6. Dube A., Nicolazzo J.A., Larson I. Assessment of plasma concentrations of (-)-epigallocatechin gallate in mice following administration of a dose reflecting consumption of a standard green tea beverage. Food Chem. 2011, 128:7-13.
7. Chow H.S., Hakim I.A., Vining D.R., Crowell J.A., Moore J.R., Chew W.M., Celaya C.A., Rodney S.R., Hara Y., Alberts D.S. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of polyphenon E in healthy individuals. Clin. Cancer Res. 2005, 11:4627-4633.
8. Ferruzzi G.M., Green R.J. Analysis of catechins from milk-tea beverages by enzyme assisted extraction followed by high performance liquid chromatography. Food Chem. 2006, 99:484-491.
9. Narumi K., Sonoda J.I., Shiotani K., Shigeru M., Shibata M., Kawachi A., Tomishige E., Sato K., Motoya T. Simultaneous detection of green tea catechins and gallic acid in human serum after ingestion of green tea tablets using ion-pair high-performance liquid chromatography with electrochemical detection. J. Chromatogr. B. 2014, 945:147-153.
10. Chu K.O., Wang C.C., Chu C.Y., Rogers M.S., Choy K.W., Pang C.P. Determination of catechins and catechin gallates in tissues by liquid chromatography with coulometric array detection and selective solid phase extraction. J. Chromatogr. B 2004, 810:187-195.
11. Masukawa Y., Matsui Y., Shimizu N., Kondou N., Endou H., Kuzukawa M., Hase T. Determination of green tea catechins in human plasma using liquid chromatography-electrospray ionization mass spectrometry. J. Chromatogr. B. 2006, 834:26-34.
12. Stalmach A., Troufflard S., Serafini M., Crozier A. Absorption, metabolism and excretion of Choladi green tea flavon-3-ols by humans. Mol. Nutr. Food Res. 2009, 53:S44-S53.
13. Guidance for Industry, Bioanalytical Method Validation, US Department ofHealth and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CV), 2001, 4-10.
14. Mochizuki M., Yamazaki S., Kano K. Kinetic analysis and mechanistic aspects of autoxidation of catechins. Biochim. Biophys. Acta. 2002, 1569:35-44.
15. Metsugi Y., Miyaji Y., Ogawara K., Higaki K., Kimura T. Appearance of double peaks in plasma concentration time profile after oral administration depends on gastric emptying profile and weight function. Pharm. Res. 2008, 25:886-895.
16. Li Q.S., Wang C.Y., Han G.Z. Application of LC-MS/MS method in pharmacokinetic study of multi-components from tea polyphenols in rats. Chin. J. New Drug. 2011, 20:817-824.
17. Godfrey K.R., Arundel P.A., Dong Z., Bryant R. Modelling the double peak phenomenon in pharmacokinetics. Comput. Methods Progr. Biomed. 2011, 104:62-69.